Source : https://pubmed.ncbi.nlm.nih.gov/34111402/
Epithelial tissues are highly sensitive to anisotropies in mechanical force, with cells altering fundamental behaviors, such as cell adhesion, migration, and cell division. 1-5 It is well known that, in...
Source : https://pubmed.ncbi.nlm.nih.gov/34111513/
Mutations in KRAS frequently occur in human cancer and are especially prevalent in pancreatic ductal adenocarcinoma (PDAC), where they have been shown to promote aggressive phenotypes. However, targeting this onco-protein...
Sotorasib is a selective irreversible inhibitor of the G12C-activated KRAS oncogene, present in approximately 13% of non–small-cell lung cancers. In a single-group, phase 2 trial involving 126 patients with previously treated KRAS –mutated NSCLC, 37% had a response.
https://www.nejm.org/doi/full/10.1056/NEJMoa2103695
Diagnostic testing companies should do a better job of turning around biomarker test results for lung cancer patients, according to a survey reported at the American Society of Clinical Oncology (ASCO) annual meeting.
/>
Source : https://www.labpulse.com/index.aspx?sec=sup&sub=gen&pag=dis&ItemID=802127
Out of 170 clinicians polled, the vast majority (98%) said that they felt it was important to get biomarker test results back in from one to two weeks, but while...
Click on the icon above to preview and download our full comprehensive coverage from Day 3 at the 2021 ASCO Virtual Conference